LSDIF (Lucy Scientific Discovery) Debt-to-Asset : 0.52 (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lucy Scientific Discovery Debt-to-Asset?

Lucy Scientific Discovery LSDIF Debt-to-Asset is 0.52 as of Dec. 2023.

Lucy Scientific Discovery's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.49 Mil. Lucy Scientific Discovery's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.72 Mil. Lucy Scientific Discovery's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $4.29 Mil. Lucy Scientific Discovery's debt to asset for the quarter that ended in Dec. 2023 was 0.52.


Lucy Scientific Discovery  (OTCPK:LSDIF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Lucy Scientific Discovery Debt-to-Asset Related Terms


Lucy Scientific Discovery Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Lucy Scientific Discovery's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery Debt-to-Asset Chart

Lucy Scientific Discovery Annual Data
Trend Jun21 Jun22 Jun23
Debt-to-Asset
0.39 1.04 0.20

Lucy Scientific Discovery Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.33 0.19 0.20 0.28 0.52

LSDIF vs INQD, ZTS, VTRS: Debt-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lucy Scientific Discovery's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lucy Scientific Discovery Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lucy Scientific Discovery's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Lucy Scientific Discovery's Debt-to-Asset falls into.



Lucy Scientific Discovery Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Lucy Scientific Discovery's Debt-to-Asset for the fiscal year that ended in Jun. 2023 is calculated as

Lucy Scientific Discovery's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.52 mean?
Lucy Scientific Discovery (LSDIF) has a Debt-to-Asset of 0.52 as of Dec. 2023. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's Debt-to-Asset too high?
Lucy Scientific Discovery's current Debt-to-Asset is 0.52.
How does Lucy Scientific Discovery's Debt-to-Asset compare to INQD and ZTS?
Lucy Scientific Discovery's Debt-to-Asset of 0.52 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Lucy Scientific Discovery and its competitors. Lucy Scientific Discovery's current Debt-to-Asset is 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current Debt-to-Asset of 0.52. The current Debt-to-Asset is 0.52. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current Debt-to-Asset is 0.52 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lucy Scientific Discovery Business Description

Address 301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.